CA3092807C - Method for indicating a presence or non-presence of aggressive prostate cancer - Google Patents
Method for indicating a presence or non-presence of aggressive prostate cancer Download PDFInfo
- Publication number
- CA3092807C CA3092807C CA3092807A CA3092807A CA3092807C CA 3092807 C CA3092807 C CA 3092807C CA 3092807 A CA3092807 A CA 3092807A CA 3092807 A CA3092807 A CA 3092807A CA 3092807 C CA3092807 C CA 3092807C
- Authority
- CA
- Canada
- Prior art keywords
- snppc
- pca
- category
- psa
- biomarkers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57434—Specifically defined cancers of prostate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Medical Informatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1251312 | 2012-11-20 | ||
| SE1251312-3 | 2012-11-20 | ||
| SE1350600-1 | 2013-05-16 | ||
| SE1350600 | 2013-05-16 | ||
| CA2891392A CA2891392C (en) | 2012-11-20 | 2013-11-20 | Method for indicating a presence or non-presence of aggressive prostate cancer |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2891392A Division CA2891392C (en) | 2012-11-20 | 2013-11-20 | Method for indicating a presence or non-presence of aggressive prostate cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA3092807A1 CA3092807A1 (en) | 2014-05-30 |
| CA3092807C true CA3092807C (en) | 2024-02-27 |
Family
ID=49619938
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3092807A Active CA3092807C (en) | 2012-11-20 | 2013-11-20 | Method for indicating a presence or non-presence of aggressive prostate cancer |
| CA2891392A Active CA2891392C (en) | 2012-11-20 | 2013-11-20 | Method for indicating a presence or non-presence of aggressive prostate cancer |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2891392A Active CA2891392C (en) | 2012-11-20 | 2013-11-20 | Method for indicating a presence or non-presence of aggressive prostate cancer |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10431326B2 (enExample) |
| EP (2) | EP2922967B1 (enExample) |
| JP (2) | JP2016503301A (enExample) |
| KR (1) | KR20150110477A (enExample) |
| AU (1) | AU2013349801B2 (enExample) |
| BR (1) | BR112015011359B1 (enExample) |
| CA (2) | CA3092807C (enExample) |
| DK (1) | DK2922967T3 (enExample) |
| ES (1) | ES2667326T3 (enExample) |
| IL (1) | IL238724A0 (enExample) |
| MY (1) | MY182773A (enExample) |
| RU (1) | RU2675370C2 (enExample) |
| WO (1) | WO2014079865A1 (enExample) |
| ZA (1) | ZA201503460B (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102150771B1 (ko) | 2012-03-05 | 2020-09-01 | 오와이 아크틱 파트너스 에이비 | 전립선 암의 위험성 및 전립선 부피를 예측하는 방법 및 장치 |
| US10428385B2 (en) | 2012-11-20 | 2019-10-01 | Phadia Ab | Prognostic method for individuals with prostate cancer |
| AU2015230017B2 (en) | 2014-03-11 | 2021-06-17 | A3P Biomedical Ab | Method for detecting a solid tumor cancer |
| US12326453B2 (en) * | 2014-03-28 | 2025-06-10 | Opko Diagnostics, Llc | Compositions and methods for active surveillance of prostate cancer |
| EA201691952A1 (ru) | 2014-03-28 | 2017-05-31 | Опкоу Дайагностикс, Ллк. | Композиции и методы, имеющие отношение к диагностике рака предстательной железы |
| MX392040B (es) | 2015-03-27 | 2025-03-21 | Opko Diagnostics Llc | Estandares de antigeno prostatico y sus usos. |
| US9858665B2 (en) * | 2015-04-03 | 2018-01-02 | Regents Of The University Of Minnesota | Medical imaging device rendering predictive prostate cancer visualizations using quantitative multiparametric MRI models |
| TWI766836B (zh) * | 2015-04-29 | 2022-06-11 | 美商Ｏｐｋｏ診斷法有限責任公司 | 用於主動監測前列腺癌之方法、電腦、系統及電腦可讀儲存媒體 |
| WO2017164699A1 (ko) * | 2016-03-24 | 2017-09-28 | 서울대학교병원 (분사무소) | 전립선암과 관련된 단일염기다형성 및 이를 이용한 유전 위험도 점수의 개발 |
| DK3270163T3 (en) * | 2016-07-15 | 2018-11-19 | Proteomedix Ag | PROCEDURE FOR DETECTING PROTEINS IN HUMAN SAMPLES AND APPLICATIONS OF SUCH PROCEDURES |
| EP3577237B1 (en) * | 2017-02-01 | 2023-07-19 | Phadia AB | Method for indicating a presence or non-presence of prostate cancer in individuals with particular characteristics |
| KR102093453B1 (ko) * | 2018-01-08 | 2020-03-25 | (주)인실리코젠 | 체형 및 대사 감수성 snp 마커 및 진단정보 제공방법 |
| WO2019144112A1 (en) | 2018-01-22 | 2019-07-25 | Phadia Ab | Method for the harmonization of assay results |
| IT201800021394A1 (it) * | 2018-12-28 | 2020-06-28 | Daniela Terracciano | Metodo in vitro per la diagnosi del cancro alla prostata |
| US11633146B2 (en) | 2019-01-04 | 2023-04-25 | Regents Of The University Of Minnesota | Automated co-registration of prostate MRI data |
| US11631171B2 (en) | 2019-01-10 | 2023-04-18 | Regents Of The University Of Minnesota | Automated detection and annotation of prostate cancer on histopathology slides |
| CN109628564B (zh) * | 2019-02-25 | 2022-02-01 | 北京市理化分析测试中心 | 一种用于检测snp多态性的引物组和利用引物组检测snp多态性的方法 |
| KR102068667B1 (ko) * | 2019-02-28 | 2020-01-21 | 주식회사 프로카젠 | 전립선암 유전위험점수 산출장치, 산출방법 및 이의 기록매체 |
| KR102371655B1 (ko) * | 2019-02-28 | 2022-03-08 | 주식회사 프로카젠 | 각 유전 변이 정보에 개별적인 가중치를 부여한 전립선암 유전위험점수 산출장치, 산출방법 및 이의 기록매체 |
| KR102371654B1 (ko) * | 2019-02-28 | 2022-03-08 | 주식회사 프로카젠 | 유전 변이의 개수에 따른 예측력을 고려한 전립선암 유전위험점수 산출장치, 산출방법 및 이의 기록매체 |
| KR102068666B1 (ko) * | 2019-02-28 | 2020-02-11 | 주식회사 프로카젠 | 인종 별 전립선암 유전위험점수 산출장치, 산출방법 및 이의 기록매체 |
| IT202000029948A1 (it) * | 2020-12-04 | 2022-06-04 | Nib Biotec S R L | Metodo per la diagnosi di tumore alla prostata in pazienti in differente fascia di età |
| JP7641532B2 (ja) * | 2020-08-28 | 2025-03-07 | 国立研究開発法人理化学研究所 | 前立腺がんの検査方法 |
| GB2599198B (en) * | 2021-06-15 | 2022-12-07 | A3P Biomedical Ab | A method for determining an appropriate time interval for further diagnostic testing for prostate cancer |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030219840A1 (en) | 2002-05-24 | 2003-11-27 | Mikolajczyk Stephen D. | Method of analyzing proenzyme forms of prostate specific antigen in serum to improve prostate cancer detection |
| FR2934698B1 (fr) * | 2008-08-01 | 2011-11-18 | Commissariat Energie Atomique | Procede de prediction pour le pronostic ou le diagnostic ou la reponse therapeutique d'une maladie et notamment du cancer de la prostate et dispositif permettant la mise en oeuvre du procede. |
| US20120021925A1 (en) * | 2009-01-19 | 2012-01-26 | Miraculins, Inc. | Diagnostic assays for prostate cancer using psp94 and psa biomarkers |
| WO2010093939A2 (en) | 2009-02-12 | 2010-08-19 | Dana-Farber Cancer Institute, Inc. | Predicting and treating prostate cancer |
| EP2576835A4 (en) * | 2010-06-01 | 2013-10-30 | Univ Laval | PROGNOSTIC MARKERS FOR THE REPRODUCTION OF PROSTATE CANCER |
| EP2611943B1 (en) | 2010-09-03 | 2017-01-04 | Wake Forest University Health Sciences | Methods and compositions for correlating genetic markers with prostate cancer risk |
| US20120202888A1 (en) | 2010-10-08 | 2012-08-09 | The Brigham And Women's Hospital, Inc. | Biomarkers of prostate cancer and predicting mortality |
| US20120150032A1 (en) * | 2010-12-13 | 2012-06-14 | Julius Gudmundsson | Sequence Variants Associated with Prostate Specific Antigen Levels |
| JP2015524052A (ja) | 2012-05-16 | 2015-08-20 | ファディア・アクチボラゲットＰｈａｄｉａ ＡＢ | 前立腺癌の存在または不存在の提示方法 |
| US10428385B2 (en) | 2012-11-20 | 2019-10-01 | Phadia Ab | Prognostic method for individuals with prostate cancer |
-
2013
- 2013-11-20 BR BR112015011359-1A patent/BR112015011359B1/pt not_active IP Right Cessation
- 2013-11-20 CA CA3092807A patent/CA3092807C/en active Active
- 2013-11-20 KR KR1020157015113A patent/KR20150110477A/ko not_active Ceased
- 2013-11-20 RU RU2015124054A patent/RU2675370C2/ru active
- 2013-11-20 MY MYPI2015701578A patent/MY182773A/en unknown
- 2013-11-20 JP JP2015542308A patent/JP2016503301A/ja active Pending
- 2013-11-20 CA CA2891392A patent/CA2891392C/en active Active
- 2013-11-20 DK DK13792689.5T patent/DK2922967T3/en active
- 2013-11-20 EP EP13792689.5A patent/EP2922967B1/en active Active
- 2013-11-20 EP EP17210720.3A patent/EP3327146A1/en not_active Withdrawn
- 2013-11-20 ES ES13792689.5T patent/ES2667326T3/es active Active
- 2013-11-20 US US14/443,970 patent/US10431326B2/en active Active
- 2013-11-20 WO PCT/EP2013/074259 patent/WO2014079865A1/en not_active Ceased
- 2013-11-20 AU AU2013349801A patent/AU2013349801B2/en active Active
-
2015
- 2015-05-10 IL IL238724A patent/IL238724A0/en unknown
- 2015-05-18 ZA ZA2015/03460A patent/ZA201503460B/en unknown
-
2018
- 2018-10-04 JP JP2018189147A patent/JP2019049559A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019049559A (ja) | 2019-03-28 |
| AU2013349801B2 (en) | 2019-03-07 |
| HK1215594A1 (en) | 2016-09-02 |
| BR112015011359A8 (pt) | 2019-10-01 |
| RU2015124054A (ru) | 2017-01-10 |
| EP3327146A1 (en) | 2018-05-30 |
| EP2922967A1 (en) | 2015-09-30 |
| BR112015011359B1 (pt) | 2022-12-06 |
| ZA201503460B (en) | 2018-11-28 |
| US20150317431A1 (en) | 2015-11-05 |
| US10431326B2 (en) | 2019-10-01 |
| ES2667326T3 (es) | 2018-05-10 |
| JP2016503301A (ja) | 2016-02-04 |
| CN105051206A (zh) | 2015-11-11 |
| KR20150110477A (ko) | 2015-10-02 |
| RU2675370C2 (ru) | 2018-12-19 |
| AU2013349801A1 (en) | 2015-05-28 |
| WO2014079865A1 (en) | 2014-05-30 |
| CA3092807A1 (en) | 2014-05-30 |
| IL238724A0 (en) | 2015-06-30 |
| EP2922967B1 (en) | 2018-01-03 |
| CA2891392A1 (en) | 2014-05-30 |
| CA2891392C (en) | 2020-11-03 |
| MY182773A (en) | 2021-02-05 |
| DK2922967T3 (en) | 2018-04-16 |
| BR112015011359A2 (pt) | 2017-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA3092807C (en) | Method for indicating a presence or non-presence of aggressive prostate cancer | |
| CA2891394C (en) | Prognostic method for individuals with prostate cancer | |
| RU2720148C9 (ru) | Способ обнаружения солидной злокачественной опухоли | |
| US20150094221A1 (en) | Method for Indicating the Presence or Non-Presence of Prostate Cancer | |
| JP2022179483A (ja) | 特定の特徴を有する個体において前立腺癌の存在または不存在を示すための方法 | |
| CN105051206B (zh) | 用于指示侵袭性前列腺癌的存在或不存在的方法 | |
| HK1215594B (en) | Method for indicating a presence or non-presence of aggressive prostate cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20200910 |
|
| EEER | Examination request |
Effective date: 20200910 |
|
| EEER | Examination request |
Effective date: 20200910 |
|
| EEER | Examination request |
Effective date: 20200910 |
|
| EEER | Examination request |
Effective date: 20200910 |
|
| EEER | Examination request |
Effective date: 20200910 |
|
| EEER | Examination request |
Effective date: 20200910 |
|
| EEER | Examination request |
Effective date: 20200910 |